Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.19% | -46.00% | -36.90% | 11.64% | 21.14% |
| Total Depreciation and Amortization | 93.51% | 27.70% | -37.90% | -39.60% | -40.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.80% | 527.57% | 518.72% | 236.18% | 227.81% |
| Change in Net Operating Assets | -16.27% | 31.25% | 101.95% | 64.02% | 74.78% |
| Cash from Operations | -47.78% | -21.78% | 1.16% | 25.78% | 34.06% |
| Capital Expenditure | 34.38% | 100.00% | -28.00% | -28.00% | -28.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Investing | 34.38% | 100.00% | 199.34% | -28.00% | -28.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 41.33% | 16.33% | 0.00% | -9.09% | 40.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 41.33% | 16.33% | 0.00% | -104.51% | -101.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.31% | -19.21% | 102.50% | -193.67% | -186.95% |